GPBAR1 and chronic kidney disease: Given that the host bile acid activated receptors FXR and TGR5 are expressed in the kidney and have the potential to modulate host inflammatory and fibrotic responses, investigation of a bile acid dysmetabolism that may contribute to or mitigate CKD progression is warranted.